NEW YORK (GenomeWeb) – Multi-gene germline testing of breast cancer patients doubles the detection of disease-causing variants that could result in a change of care, compared to BRCA1- and BRCA2-only testing, though it does not increase prophylactic breast removal, according to a large new retrospective population-based study.